Skip to main content

Helus Pharma Inc.

HELP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001833141

In the last 90 days, Helus Pharma Inc. insiders filed 8 open-market purchases and 0 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $197.6M in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysLast 90 days, $8.42M in total
8
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +19 vs. previous quarter
99
13F valueReported value at the end of Q2 2026
$197.6M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in CAD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
CAD -113.1M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
2.66M
Shares sold short
Change
−345.7K
−11.5% vs. previous
Days to cover
2.05
At average daily volume

Superinvestors holding HELP, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HELP at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Helus Pharma Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 1, 2026 (view filing)8:13 PM ETSep 292 daysCavers GregChief Financial OfficerPPurchase+3.00K$12.91+$38.7KNew position3.00K after
Sep 21, 2026 (view filing)5:07 PM ETSep 21Same dayHalstead MichaelChief Executive OfficerPPurchase+100.0K$13.47+$1.35M+145.8%168.6K after
Sep 11, 2026 (view filing)9:04 AM ETSep 83 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$12.47+$1.25M+2.4%4.27M afterDuplicate filing
Sep 11, 2026 (view filing)9:03 AM ETSep 83 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$12.47+$1.25M+2.4%4.27M after
Sep 11, 2026 (view filing)9:01 AM ETSep 83 daysLateSo Eric H. L.Executive ChairPPurchase+100.0K$12.39+$1.24M+2.3%4.47M after
Sep 10, 2026 (view filing)6:21 AM ETSep 46 daysLateSo Eric H. L.Executive ChairPPurchase+100.0K$12.09+$1.21M+2.3%4.37M after
Sep 10, 2026 (view filing)6:19 AM ETSep 37 daysLateGlavine PaulChief Growth OfficerPPurchase+100.0K$11.78+$1.18M+2.5%4.17M after
Sep 9, 2026 (view filing)5:47 PM ETSep 18 daysLateSo Eric H. L.Executive ChairPPurchase+95.0K$11.81+$1.12M+2.3%4.27M after
Sep 9, 2026 (view filing)11:03 AM ETAug 319 daysLateGlavine PaulChief Growth OfficerPPurchase+90.0K$11.59+$1.04M+2.3%4.07M after

Top 10 13F holders, Q2 2026

See all 99 holders

The largest institutional positions in Helus Pharma Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HELP in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
VR Adviser, LLC3,851,654$25.5M0.77%00.0%Unchanged
OrbiMed Advisors LLC3,271,400$21.6M0.41%−561,443−14.6%Reduced
Adage Capital Partners GP, L.L.C.3,060,000$20.2M0.03%+2,360,000+337.1%Added
Millennium Management LLC2,632,156$17.4M0.01%+216,315+9.0%Added
Rosalind Advisors, Inc.1,956,814$12.9M4.86%+425,000+27.7%Added
Sphera Funds Management Ltd.1,620,753$10.7M1.53%+633,663+64.2%Added
Acorn Capital Advisors, LLC1,540,266$10.2M2.78%00.0%Unchanged
DCF Advisers, LLC1,434,988$9.49M2.48%+743,000+107.4%Added
Sio Capital Management, LLC1,300,000$8.59M1.47%+1,300,000New
Nan Fung Group Holdings Ltd987,222$6.53M4.96%+527,222+114.6%Added

Holders of 5% or more of HELP

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Helus Pharma Inc..

Largest holders of HELP from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Venrock Healthcare Capital Partners III, L.P.13G9.90%5.11M sharesNewNov 7, 20251 filingNov 7, 2025SEC
Adage Capital Management, L.P.13G/A7.48%5.48M shares+2.19 ppfrom 5.29%Aug 12, 20262 filingsNov 12, 2026SEC
So Eric H. L.13D5.80%4.42M sharesNewSep 9, 20261 filingSep 9, 2026SEC
Glavine Paul13D5.80%4.41M sharesNewSep 9, 20261 filingSep 9, 2026SEC
Millennium Management LLC13G/A5.70%2.83M shares+0.70 ppfrom 5.00%Mar 26, 20263 filingsApr 22, 2026SEC